A discordant sib-pair linkage analysis of age-related macular degeneration.

PubWeight™: 1.51‹?› | Rank: Top 4%

🔗 View Article (PMID 16020308)

Published in Ophthalmic Genet on June 01, 2005

Authors

Susan L Santangelo1, Chen-Hsing Yen, Stephen Haddad, Jesen Fagerness, Christine Huang, Johanna M Seddon

Author Affiliations

1: Psychiatric & Neurodevelopmental Genetics Unit, Center for Human Genetic Research, Massachusetts General Hospital, 149 13th Street, Charlestown, MA, USA. ssantang@psych.mgh.harvard.edu

Articles by these authors

Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration. Nat Genet (2006) 7.49

Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration. Proc Natl Acad Sci U S A (2010) 4.30

Variation in complement factor 3 is associated with risk of age-related macular degeneration. Nat Genet (2007) 4.23

Age-related macular degeneration. Lancet (2012) 4.17

Seven new loci associated with age-related macular degeneration. Nat Genet (2013) 3.81

Identification of common variants associated with human hippocampal and intracranial volumes. Nat Genet (2012) 3.73

A rare penetrant mutation in CFH confers high risk of age-related macular degeneration. Nat Genet (2011) 3.55

Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC). Proc Natl Acad Sci U S A (2010) 3.33

Variation near complement factor I is associated with risk of advanced AMD. Eur J Hum Genet (2008) 3.29

Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19. Ophthalmology (2005) 3.28

Potential public health impact of Age-Related Eye Disease Study results: AREDS report no. 11. Arch Ophthalmol (2003) 3.17

The relationship of dietary carotenoid and vitamin A, E, and C intake with age-related macular degeneration in a case-control study: AREDS Report No. 22. Arch Ophthalmol (2007) 3.02

CFH and LOC387715/ARMS2 genotypes and treatment with antioxidants and zinc for age-related macular degeneration. Ophthalmology (2008) 2.90

The association between complement component 2/complement factor B polymorphisms and age-related macular degeneration: a HuGE review and meta-analysis. Am J Epidemiol (2012) 2.87

Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up. J Clin Oncol (2005) 2.37

The genetics of age-related macular degeneration: a review of progress to date. Surv Ophthalmol (2006) 2.37

Meta-analysis of genome scans of age-related macular degeneration. Hum Mol Genet (2005) 2.34

Risk of soft tissue sarcomas by individual subtype in survivors of hereditary retinoblastoma. J Natl Cancer Inst (2007) 2.32

Evidence for the default network's role in spontaneous cognition. J Neurophysiol (2010) 2.32

The relationship of dietary lipid intake and age-related macular degeneration in a case-control study: AREDS Report No. 20. Arch Ophthalmol (2007) 2.12

Troponin criteria for myocardial infarction after percutaneous coronary intervention. Arch Intern Med (2012) 2.09

Multiple measures of HIV burden in blood and tissue are correlated with each other but not with clinical parameters in aviremic subjects. AIDS (2003) 2.05

Correction of phenotype misclassification based on high-discrimination genetic predictive risk models. Epidemiology (2012) 2.01

Common variants near FRK/COL10A1 and VEGFA are associated with advanced age-related macular degeneration. Hum Mol Genet (2011) 1.98

The relationship of dietary omega-3 long-chain polyunsaturated fatty acid intake with incident age-related macular degeneration: AREDS report no. 23. Arch Ophthalmol (2008) 1.93

The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data. Brain Imaging Behav (2014) 1.90

Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes. Invest Ophthalmol Vis Sci (2009) 1.86

A phase II randomized study of HIV-specific T-cell gene therapy in subjects with undetectable plasma viremia on combination antiretroviral therapy. Mol Ther (2002) 1.83

Partitioning the heritability of Tourette syndrome and obsessive compulsive disorder reveals differences in genetic architecture. PLoS Genet (2013) 1.68

Prospective study of intake of fruits, vegetables, vitamins, and carotenoids and risk of age-related maculopathy. Arch Ophthalmol (2004) 1.63

Prospective assessment of genetic effects on progression to different stages of age-related macular degeneration using multistate Markov models. Invest Ophthalmol Vis Sci (2012) 1.63

Association between treatment-emergent suicidal ideation with citalopram and polymorphisms near cyclic adenosine monophosphate response element binding protein in the STAR*D study. Arch Gen Psychiatry (2007) 1.53

Family-based association study of lithium-related and other candidate genes in bipolar disorder. Arch Gen Psychiatry (2008) 1.53

Genetic epidemiology: successes and challenges of genome-wide association studies using the example of age-related macular degeneration. Am J Ophthalmol (2010) 1.48

Cause-specific mortality in long-term survivors of retinoblastoma. J Natl Cancer Inst (2009) 1.42

In-hospital and 1-year outcomes among unselected percutaneous coronary intervention patients treated with either sirolimus- or paclitaxel-eluting stents: results from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry. JACC Cardiovasc Interv (2009) 1.39

Review of genetics in age related macular degeneration. Semin Ophthalmol (2007) 1.37

Associations of CFHR1-CFHR3 deletion and a CFH SNP to age-related macular degeneration are not independent. Nat Genet (2010) 1.35

The LOC387715 gene, smoking, body mass index, environmental associations with advanced age-related macular degeneration. Hum Hered (2007) 1.30

Association of variants in the LIPC and ABCA1 genes with intermediate and large drusen and advanced age-related macular degeneration. Invest Ophthalmol Vis Sci (2011) 1.30

Serum lipid biomarkers and hepatic lipase gene associations with age-related macular degeneration. Ophthalmology (2010) 1.29

Pharmacogenetic analysis of genes implicated in rodent models of antidepressant response: association of TREK1 and treatment resistance in the STAR(*)D study. Neuropsychopharmacology (2008) 1.29

Systematic review of women veterans' health: update on successes and gaps. Womens Health Issues (2011) 1.27

In-hospital and 1-year outcomes among percutaneous coronary intervention patients with chronic kidney disease in the era of drug-eluting stents: a report from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry. JACC Cardiovasc Interv (2009) 1.24

Variations in apolipoprotein E frequency with age in a pooled analysis of a large group of older people. Am J Epidemiol (2011) 1.19

ARMS2/HTRA1 locus can confer differential susceptibility to the advanced subtypes of age-related macular degeneration. Am J Ophthalmol (2010) 1.19

Evidence of association of APOE with age-related macular degeneration: a pooled analysis of 15 studies. Hum Mutat (2011) 1.17

Heritability and genome-wide association study to assess genetic differences between advanced age-related macular degeneration subtypes. Ophthalmology (2012) 1.16

A prospective study of diabetes, lifestyle factors, and glaucoma among African-American women. Ann Epidemiol (2011) 1.15

Complement factor D in age-related macular degeneration. Invest Ophthalmol Vis Sci (2011) 1.14

Association between CHRNA5 genetic variation at rs16969968 and brain reactivity to smoking images in nicotine dependent women. Drug Alcohol Depend (2011) 1.14

Corticotropin-releasing hormone receptor type 1 (CRHR1) genetic variation and stress interact to influence reward learning. J Neurosci (2011) 1.10

Dietary omega-3 fatty acids, other fat intake, genetic susceptibility, and progression to incident geographic atrophy. Ophthalmology (2013) 1.08

Sexually dimorphic effects of four genes (COMT, SLC6A2, MAOA, SLC6A4) in genetic associations of ADHD: a preliminary study. Am J Med Genet B Neuropsychiatr Genet (2008) 1.05

Predictors of family accommodation in obsessive-compulsive disorder. Ann Clin Psychiatry (2008) 1.05

Corticotrophin-releasing hormone type 1 receptor gene (CRHR1) variants predict posttraumatic stress disorder onset and course in pediatric injury patients. Dis Markers (2011) 1.04

Hormone therapy and age-related macular degeneration: the Women's Health Initiative Sight Exam Study. Arch Ophthalmol (2006) 1.03

A genetic family-based association study of OLIG2 in obsessive-compulsive disorder. Arch Gen Psychiatry (2007) 1.02

Genetic profile for five common variants associated with age-related macular degeneration in densely affected families: a novel analytic approach. Eur J Hum Genet (2009) 1.00

Increased risk of secondary uterine leiomyosarcoma in hereditary retinoblastoma. Gynecol Oncol (2011) 0.97

rs5888 variant of SCARB1 gene is a possible susceptibility factor for age-related macular degeneration. PLoS One (2009) 0.97

Family-based genetic association study of DLGAP3 in Tourette Syndrome. Am J Med Genet B Neuropsychiatr Genet (2010) 0.97

Clinical and genetic dissection of anger expression and CREB1 polymorphisms in major depressive disorder. Biol Psychiatry (2007) 0.96

Evaluation of new and established age-related macular degeneration susceptibility genes in the Women's Health Initiative Sight Exam (WHI-SE) Study. Am J Ophthalmol (2011) 0.93

Association between reproductive and hormonal factors and age-related maculopathy in postmenopausal women. Am J Ophthalmol (2002) 0.93

Kidney function, albuminuria and age-related macular degeneration in NHANES III. Nephrol Dial Transplant (2011) 0.93

Relationship between genetic variation in the glutaminase gene GLS1 and brain glutamine/glutamate ratio measured in vivo. Biol Psychiatry (2011) 0.91

Geographic atrophy in age-related macular degeneration and TLR3. N Engl J Med (2009) 0.91

Pharmacogenetic-guided psychiatric intervention associated with increased adherence and cost savings. Am J Manag Care (2014) 0.90

Cross-disorder genome-wide analyses suggest a complex genetic relationship between Tourette's syndrome and OCD. Am J Psychiatry (2014) 0.90

Variation in TREK1 gene linked to depression-resistant phenotype is associated with potentiated neural responses to rewards in humans. Hum Brain Mapp (2010) 0.89

Tobacco use in adult long-term survivors of retinoblastoma. Cancer Epidemiol Biomarkers Prev (2006) 0.89

Impact of drug eluting stent length on outcomes of percutaneous coronary intervention (from the EVENT registry). Am J Cardiol (2012) 0.88

Dietary glycemic load and risk of age-related cataract. Am J Clin Nutr (2004) 0.87

Cancer screening practices of adult survivors of retinoblastoma at risk of second cancers. Cancer (2008) 0.85

Association between polymorphisms in GRIK2 gene and obsessive-compulsive disorder: a family-based study. CNS Neurosci Ther (2010) 0.85

The Guinea pig as a preclinical model for demonstrating the efficacy and safety of statins. J Pharmacol Exp Ther (2007) 0.84

Outcome predictors for severe obsessive-compulsive patients in intensive residential treatment. J Psychiatr Res (2005) 0.83

Investigation of parent-of-origin effects in ADHD candidate genes. Am J Med Genet B Neuropsychiatr Genet (2007) 0.83

Automated discovery and quantification of image-based complex phenotypes: a twin study of drusen phenotypes in age-related macular degeneration. Invest Ophthalmol Vis Sci (2011) 0.83

Genetic factors for choroidal neovascularization associated with high myopia. Invest Ophthalmol Vis Sci (2012) 0.82

Pyrrolidine amides of pyrazolodihydropyrimidines as potent and selective KV1.5 blockers. Bioorg Med Chem Lett (2010) 0.82

Genotype-phenotype analysis of ABCR variants in macular degeneration probands and siblings. Invest Ophthalmol Vis Sci (2002) 0.82

Dietary folate, B vitamins, genetic susceptibility and progression to advanced nonexudative age-related macular degeneration with geographic atrophy: a prospective cohort study. Am J Clin Nutr (2016) 0.81

Incidence and clinical outcome of minor surgery in the year after drug-eluting stent implantation: results from the Evaluation of Drug-Eluting Stents and Ischemic Events Registry. Am Heart J (2011) 0.81

Cystoid macular edema without macular thickening: a retrospective optical coherence tomographic study. Retina (2010) 0.81

(3R,5S,E)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(methyl(1-methyl-1h-1,2,4-triazol-5-yl)amino)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoic acid (BMS-644950): a rationally designed orally efficacious 3-hydroxy-3-methylglutaryl coenzyme-a reductase inhibitor with reduced myotoxicity potential. J Med Chem (2008) 0.80

Aryl sulfonamido indane inhibitors of the Kv1.5 ion channel. Bioorg Med Chem Lett (2007) 0.80

Smoking cessation and risk of cataract extraction among US women and men. Am J Epidemiol (2002) 0.78

Oral delivery of highly lipophilic poorly water-soluble drugs: spray-dried dispersions to improve oral absorption and enable high-dose toxicology studies of a P2Y1 antagonist. J Pharm Sci (2014) 0.78

Implementing GermWatcher, an enterprise infection control application. AMIA Annu Symp Proc (2006) 0.78

A platelet target for venous thrombosis? P2Y1 deletion or antagonism protects mice from vena cava thrombosis. J Thromb Thrombolysis (2012) 0.77